Co-agonists of the GLP-1 and amylin receptors

MYPI2025003614A0Undetermined Publication Date: 2022-06-18NOVO NORDISK AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003614
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-06-16
Filing Date
2021-12-17
Publication Date
2022-06-18
Patent Text Reader

Abstract

The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.
Need to check novelty before this filing date? Find Prior Art